Cargando…
Silencing the PIK3CA Gene Enhances the Sensitivity of Childhood Leukemia Cells to Chemotherapy Drugs by Suppressing the Phosphorylation of Akt
PURPOSE: This study aimed to investigate the effects of PIK3CA on the sensitivity of acute B lymphocytic leukemia cells (Nalm-6 cells) to chemotherapy drugs. MATERIALS AND METHODS: Children's normal B lymphocytes and Nalm-6 cells were cultured. Nalm-6 cells were transfected with PIK3CA siRNA (s...
Autores principales: | Liang, Xiuling, Xin, Xianfang, Qi, Dongmei, Fu, Chengyan, Ding, Mingde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342719/ https://www.ncbi.nlm.nih.gov/pubmed/30666840 http://dx.doi.org/10.3349/ymj.2019.60.2.182 |
Ejemplares similares
-
PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
por: Liedtke, Cornelia, et al.
Publicado: (2008) -
Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013) -
PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma
por: Ross, R. L., et al.
Publicado: (2016) -
PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer
por: Kim, Ji-Won, et al.
Publicado: (2017) -
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
por: Wang, Qiang, et al.
Publicado: (2018)